Signal active
Contact Information
Social
N/A
Primary Organization
1997
131
25
63
11-50
Biotechnology
Bio
Dr. Charo is a Senior Investigator/Associate Director at the Gladstone Institute of Cardiovascular Disease and a Venture Partner at Bay City Capital. He studies the role of chemokines in leukocyte trafficking and inflammation. His group cloned the chemokine receptor CCR2, and showed that it is a major driver for the recruitment of monocyte/macrophages to developing atherosclerotic lesions. Dr. Charo was one of the founding scientists of COR Therapeutics, which was subsequently acquired by Millennium. He has served on the editorial boards of the Journal of Clinical Investigation and the Journal of Biological Chemistry, on the NIH Pathology A Study Section, and on numerous Scientific Advisory Boards.
Location
N/A
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Israel Charo is the Scientific Advisory Board at Bay City Capital. With a background in Biotechnology, Israel Charo has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.